MedPath
HSA Approval

MILRINONE-BAXTER CONCENTRATED SOLUTION FOR INJECTION 10MG/10ML

SIN15249P

MILRINONE-BAXTER CONCENTRATED SOLUTION FOR INJECTION 10MG/10ML

MILRINONE-BAXTER CONCENTRATED SOLUTION FOR INJECTION 10MG/10ML

May 26, 2017

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION, CONCENTRATE

INTRAVENOUS

Medical Information

C01CE02

milrinone

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Pharmaceuticals India Private Limited

Active Ingredients

Milrinone (as lactate)

1mg/mL

Milrinone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MILRINONE-BAXTER CONCENTRATED SOLUTION FOR INJECTION 10MG/10ML - HSA Approval | MedPath